Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
Pharma
Orphan drug market to reach $270B by 2028: Evaluate
The high-flying drug sector is set for a slight sales growth slowdown throughout the decade, according to Evaluate's 2024 Orphan Drug Report.
Zoey Becker
Apr 24, 2024 12:01am
AbbVie tops, J&J drops as physicians rank immunology players
Apr 19, 2024 7:30am
J&J reports $133M in sales for new multiple myeloma med Tecvayli
Apr 16, 2024 11:28am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am
FDA weighs another approvable myeloma endpoint. What's at stake?
Apr 9, 2024 9:00am
J&J, Legend's Carvykti quickly leaps ahead of BMS' rival CAR-T
Apr 8, 2024 8:30am